Evidence map›Paper›PMID 34235673›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2021

A Multistress Model for High Throughput Screening Against Nonreplicating Mycobacterium tuberculosis.

Ben Gold, Thulasi Warrier, Carl Nathan

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. ACS medicinal chemistry letters · 2023
    Article
  5. Target Identification in Anti-Tuberculosis Drug Discovery.International journal of molecular sciences · 2023
    Review
  6. Review
  7. In Vitro and In Vivo Inhibition of theJournal of medicinal chemistry · 2022
    Article
  8. The evolving biology ofFrontiers in cellular and infection microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ben GoldDepartment of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA. bsg2001@med.cornell.edu.
Thulasi WarrierBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Carl NathanDepartment of Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Models of nonreplication help us understand the biology of persistent Mycobacterium tuberculosis. High throughput screening (HTS) against nonreplicating M. tuberculosis may lead to identification of tool compounds that affect pathways on which bacterial survival depends in such states and to development of drugs that can overcome phenotypic resistance to conventional antimycobacterial agents, which are mostly active against replicating M. tuberculosis. We describe a multistress model of nonreplication that mimics some of the microenvironmental conditions that M. tuberculosis faces in the host as adapted for HTS. The model includes acidic pH, mild hypoxia, a flux of nitric oxide, and other reactive nitrogen intermediates arising from nitrite at low pH and low concentrations of a fatty acid (butyrate) as a carbon source.

Indexed as

Stress, PhysiologicalAntitubercular AgentsHigh-Throughput Screening AssaysHumansHydrogen-Ion ConcentrationHypoxiaMicrobial Sensitivity TestsMycobacterium tuberculosisNitric OxideTuberculosisAntitubercular AgentsNitric OxideAcidic pHAntibioticsFatty acidsHigh-throughput screeningHypoxiaMycobacterium tuberculosisNitric oxideNonreplicationPhenotypic toleranceReactive nitrogen species

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.